MIT Technology Review October 23, 2018
Skeptics say drugs based on genetic insights have underdelivered. But look carefully and they’re everywhere.
The growing tally of personalized or targeted medicines consists of those drugs whose label includes information about how genetic makeup can affect a person’s response to a drug.
Sometime this fall, the number of people who have spit in a tube and sent their DNA to the largest consumer DNA testing companies, like Ancestry and 23andMe, is likely to top 20 million. The list by now is certain to include some of your classmates and neighbors. If you are just tuning in, this figure will seem huge. And you might wonder: how did we get here?
The answer is little by little. The number of...
Today's Sponsors
Today's Sponsor